TNFRSF10B and hepatocellular carcinoma: The examples of reduced TRAIL receptor include loss of DR4 expression in lung squamous cell carcinoma (86) and reduced DR4 and DR5 expression in hepatocellular carcinoma (HCC), which correlated with shorter overall 5-year survival of patients (87).